Home / Inspections / 1288360

FDA Inspection 1288360 — ENDO USA, Inc

ENDO USA, Inc — FEI 2410861

The FDA completed an inspection of ENDO USA, Inc on September 26, 2025 in Rye, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 26, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rye, NY (United States)

Facility

Other inspections at this facility

  • 1136893 (NAI Wed Mar 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 963017 (NAI Wed Jan 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 851401 (VAI Mon Oct 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 809209 (VAI Fri Dec 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 764681 (NAI Fri Jan 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources